Commercializing products in the musculoskeletal segment of the marketplace - Adam Gridley, President and CEO, Histogenics Corp 00:00:00

Share On Facebook Share On Twitter

Histogenics is a leading regenerative medicine company developing and commercializing novel tissue therapies that may offer more rapid and durable recoveries for patients with pain and loss of function due to musculoskeletal conditions.

Recent Videos